Ngā hua rapu - Wu, Xue‐Ru
- E whakaatu ana i te 1 - 20 hua o te 92
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Oncogenic HRAS activates epithelial-mesenchyme transition and confers stemness to p53-deficient urothelial cells to drive muscle invasion of basal subtype carcinomas mā He, Feng, Melamed, Jonathan, Tang, Moon-shong, Huang, Chuanshu, Wu, Xue-Ru
I whakaputaina 2015Text -
11
-
12
-
13
-
14
-
15
RhoGDI SUMOylation at Lys-138 Increases Its Binding Activity to Rho GTPase and Its Inhibiting Cancer Cell Motility mā Yu, Jianxiu, Zhang, Dongyun, Liu, Jinyi, Li, Jingxia, Yu, Yonghui, Wu, Xue-Ru, Huang, Chuanshu
I whakaputaina 2012Text -
16
FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma mā Zhou, Haiping, He, Feng, Mendelsohn, Cathy L., Tang, Moon-shong, Huang, Chuanshu, Wu, Xue-Ru
I whakaputaina 2016Text -
17
PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein mā Peng, Minggang, Wang, Jingjing, Zhang, Dongyun, Jin, Honglei, Li, Jingxia, Wu, Xue-Ru, Huang, Chuanshu
I whakaputaina 2018Text -
18
The RING domain in the anti-apoptotic protein XIAP stabilizes c-Myc protein and preserves anchorage-independent growth of bladder cancer cells mā Jiang, Guosong, Huang, Chao, Liao, Xin, Li, Jingxia, Wu, Xue-Ru, Zeng, Fuqing, Huang, Chuanshu
I whakaputaina 2019Text -
19
-
20
Cyclin D1 Downregulation Contributes to Anti-Cancer Effect of Isorhapontigenin (ISO) on Human Bladder Cancer Cells mā Fang, Yong, Cao, Zipeng, Hou, Qi, Ma, Chen, Yao, Chunsuo, Li, Jingxia, Wu, Xue-Ru, Huang, Chuanshu
I whakaputaina 2013Text